(Q89493552)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28071789%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

title

Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E-/- mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28071789%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28071789%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

author name string

Andrés Laguna-Fernandez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28071789%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Hildur Arnardottir

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28071789%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Craig E Wheelock

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28071789%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Mauro Perretti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28071789%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Göran K Hansson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28071789%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Magnus Bäck

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28071789%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

publication date

14 February 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28071789%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Pharmacology

5 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28071789%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

volume

174

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28071789%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

issue

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28071789%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

page(s)

4043-4054

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28071789%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

5 April 2020

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC5659998/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Pro-resolving lipid mediators are leads for resolution physiology

1 reference

12 December 2020

Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis

1 reference

12 December 2020

Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma

1 reference

12 December 2020

Formyl-Peptide Receptor 2/3/Lipoxin A4 Receptor Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease

1 reference

12 December 2020

Anti-inflammatory therapies for atherosclerosis

1 reference

12 December 2020

Leukotriene B4 pathway activation and atherosclerosis in obstructive sleep apnea.

1 reference

12 December 2020

FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis.

1 reference

12 December 2020

The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques

1 reference

12 December 2020

Experimental design and analysis and their reporting: new guidance for publication in BJP.

1 reference

12 December 2020

The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability

1 reference

12 December 2020

Animal research: reporting in vivo experiments: the ARRIVE guidelines

1 reference

12 December 2020

Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia

1 reference

12 December 2020

The leukotriene B4 receptor (BLT) antagonist BIIL284 decreases atherosclerosis in ApoE-/- mice.

1 reference

12 December 2020

Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice

1 reference

12 December 2020

Cutting Edge: Lipoxins Rapidly Stimulate Nonphlogistic Phagocytosis of Apoptotic Neutrophils by Monocyte-Derived Macrophages

1 reference

12 December 2020

Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation

1 reference

12 December 2020

Apoptotic cell death and efferocytosis in atherosclerosis

1 reference

12 December 2020

Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP.

1 reference

12 December 2020

Lipoxin A4 inhibits the production of proinflammatory cytokines induced by β-amyloid in vitro and in vivo

1 reference

12 December 2020

Targeting formyl peptide receptor 2 reduces leukocyte-endothelial interactions in a murine model of stroke.

1 reference

12 December 2020

Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement.

1 reference

12 December 2020

Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs

1 reference

12 December 2020

Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue

1 reference

12 December 2020

Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice

1 reference

12 December 2020

A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation

1 reference

12 December 2020

Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?

1 reference

12 December 2020

The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors

1 reference

12 December 2020

Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy

1 reference

12 December 2020

International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family

1 reference

12 December 2020

Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease

1 reference

12 December 2020

Progress and challenges in translating the biology of atherosclerosis

1 reference

12 December 2020

Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7

1 reference

12 December 2020

The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

1 reference

12 December 2020

Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense.

1 reference

12 December 2020

Annexin A1 counteracts chemokine-induced arterial myeloid cell recruitment.

1 reference

12 December 2020

Aspirin-triggered 15-epi-lipoxin A₄ signals through FPR2/ALX in vascular smooth muscle cells and protects against intimal hyperplasia after carotid ligation

1 reference

12 December 2020

Identifiers

DOI

10.1111/BPH.13707

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28071789%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28071789%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

PubMed publication ID

28071789

1 reference